These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2703917)

  • 21. Ascorbate on cell growth and differentiation.
    Alcaín FJ; Burón MI
    J Bioenerg Biomembr; 1994 Aug; 26(4):393-8. PubMed ID: 7844114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring of ascorbate at a constant rate in cell culture: effect on cell growth.
    Chepda T; Cadau M; Girin P; Frey J; Chamson A
    In Vitro Cell Dev Biol Anim; 2001 Jan; 37(1):26-30. PubMed ID: 11249202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin C preferential toxicity for malignant melanoma cells.
    Bram S; Froussard P; Guichard M; Jasmin C; Augery Y; Sinoussi-Barre F; Wray W
    Nature; 1980 Apr; 284(5757):629-31. PubMed ID: 7366735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer cell growth and extracellular matrix remodeling mechanism of ascorbate; beneficial modulation by P. leucotomos.
    Philips N; Dulaj L; Upadhya T
    Anticancer Res; 2009 Aug; 29(8):3233-8. PubMed ID: 19661340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer effects of high-dose ascorbate on canine melanoma cell lines.
    Shin H; Nam A; Song KH; Lee K; Rebhun RB; Seo KW
    Vet Comp Oncol; 2018 Dec; 16(4):616-621. PubMed ID: 30188000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effect of ascorbate on cell growth: relation to catalase activity.
    Nemoto S; Otsuka M; Arakawa N
    J Nutr Sci Vitaminol (Tokyo); 1996 Apr; 42(2):77-85. PubMed ID: 8780966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in anchorage-dependent growth and tumorigenicities between transformed C3H/10T 1/2 cells with morphologies that are or are not reverted to a normal phenotype by ascorbic acid.
    Benedict WF; Wheatley WL; Jones PA
    Cancer Res; 1982 Mar; 42(3):1041-5. PubMed ID: 7059969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA damage and selective toxicity of dopa and ascorbate:copper in human melanoma cells.
    Parsons PG; Morrison LE
    Cancer Res; 1982 Sep; 42(9):3783-8. PubMed ID: 6809313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell death by oxidative stress and ascorbic acid regeneration in human neuroectodermal cell lines.
    De Laurenzi V; Melino G; Savini I; Annicchiarico-Petruzzelli M; Finazzi-Agrò A; Avigliano L
    Eur J Cancer; 1995; 31A(4):463-6. PubMed ID: 7576946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ascorbic acid on carcinogenicity and acute toxicity of nickel subsulfide, and on tumor transplants growth in gulonolactone oxidase knock-out mice and wild-type C57BL mice.
    Kasprzak KS; Diwan BA; Kaczmarek MZ; Logsdon DL; Fivash MJ; Salnikow K
    Toxicol Appl Pharmacol; 2011 Nov; 257(1):32-7. PubMed ID: 21878346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restoring physiological levels of ascorbate slows tumor growth and moderates HIF-1 pathway activity in Gulo(-/-) mice.
    Campbell EJ; Vissers MC; Bozonet S; Dyer A; Robinson BA; Dachs GU
    Cancer Med; 2015 Feb; 4(2):303-14. PubMed ID: 25354695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium ascorbate potentiates the growth inhibitory effect of certain agents on neuroblastoma cells in culture.
    Prasad KN; Sinha PK; Ramanujam M; Sakamoto A
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):829-32. PubMed ID: 284405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ascorbic acid inhibits chemically induced uroporphyria in ascorbate-requiring rats.
    Sinclair PR; Gorman N; Sinclair JF; Walton HS; Bement WJ; Lambrecht RW
    Hepatology; 1995 Aug; 22(2):565-72. PubMed ID: 7635426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between specific dietary factors and experimental chemotherapy of metastatic melanoma.
    Meadows GG; Abdallah RM; Starkey JR
    Cancer Chemother Pharmacol; 1986; 16(3):229-36. PubMed ID: 3698164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ascorbic acid and 6-deoxy-6-chloro-ascorbic acid: potential anticancer drugs.
    Osmak M; Kovacek I; Ljubenkov I; Spaventi R; Eckert-Maksić M
    Neoplasma; 1997; 44(2):101-7. PubMed ID: 9201289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of erythorbic acid on ascorbic acid retention and elimination in the mouse.
    Tsao CS; Salimi SL
    Int J Vitam Nutr Res; 1983; 53(3):258-64. PubMed ID: 6629665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of dietary ascorbic acid on cholesterol 7 alpha-hydroxylase activity in the rat.
    Holloway DE; Guiry VC; Holloway BA; Rivers JM
    Int J Vitam Nutr Res; 1984; 54(4):333-7. PubMed ID: 6526599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo and in vitro antitumor effect of ascorbic acid, lysine, proline and green tea extract on human melanoma cell line A2058.
    Roomi MW; Ivanov V; Netke S; Kalinovsky T; Niedzwiecki A; Rath M
    In Vivo; 2006; 20(1):25-32. PubMed ID: 16433024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro.
    Sarna S; Bhola RK
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):327-33. PubMed ID: 8010874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of pyridoxal treatment in controlling the growth of melanomas in cell culture and an animal pilot study.
    Maksymowych AB; Robertson NM; Litwack G
    Anticancer Res; 1993; 13(6A):1925-37. PubMed ID: 8297098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.